Form D — Tempo Therapeutics, Inc.
0001813688-26-000003 · filed Sep 11, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $14,500,000
- Reported amount sold
- $14,000,000
- Minimum investment
- $0
- Investors
- 43
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Tempo Therapeutics, Inc.
- CIK
- 1813688
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3030 BUNKER HILL STREET
SAN DIEGO, CA 92109 - Phone
- 6192027445
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Westbrook Weaver · Executive OfficerSAN DIEGO, CA Find on LinkedIn ↗
-
Donald Griffin · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Biren Mehta · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Steven Sands · DirectorSAN DIEGO, CA Find on LinkedIn ↗
-
Eric Richman · Executive OfficerSan Diego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗